Streetbeat News

ALX

Alexander's, Inc.

Industry

REIT - Retail

Alexander's, Inc. is a real estate investment trust which has seven properties in the greater New York City metropolitan area.

Open

212.11

Mkt cap

1.1B

Volume

8.4K

High

212.57

P/E Ratio

25.13

52-wk high

251.63

Low

211.16

Div yield

0.08

52-wk low

184.76

ALX, HAFC, and FHB have been listed as Zacks Rank #1 (Strong Buy) income stocks as of March 13, 2025. This indicates a strong recommendation for investors seeking income-generating stocks.

Portfolio Pulse from

March 13, 2025 | 9:45 am

ALX, VLY, and HAFC have been listed as Zacks Rank #1 (Strong Buy) income stocks as of March 11, 2025. This indicates a strong recommendation for investors seeking income-generating stocks.

Portfolio Pulse from

March 11, 2025 | 9:45 am

ALX Oncology has reported its Q4 and full-year 2024 financial results, highlighting positive data from its ASPEN-06 Phase 2 trial. The trial showed that evorpacept provides a strong response and durable clinical benefit in HER2-positive gastric cancer patients, presented at the 2025 ASCO GI.

Portfolio Pulse from

March 06, 2025 | 9:15 pm

ALX Oncology is advancing its clinical development program for evorpacept, focusing on breast and colorectal cancers. The company is also progressing its EGFR-targeted ADC candidate, ALX2004, with an IND submission planned for Q1 2025. Strategic resource optimizations are being implemented to extend the cash runway into Q4 2026.

Portfolio Pulse from

March 05, 2025 | 1:15 pm

ALX Oncology Holdings Inc. will release its Q4 and full year 2024 financial results on March 6, 2025, before the market opens.

Portfolio Pulse from

February 27, 2025 | 1:15 pm

ALX Oncology Holdings Inc. will host a virtual R&D Day on March 5, 2025, to discuss advancements in their cancer treatment therapies.

Portfolio Pulse from

February 18, 2025 | 1:15 pm

Alexander's (ALX) reported Q4 funds from operations (FFO) of $4.06 per share, surpassing the Zacks Consensus Estimate of $3.71 per share. However, this is a decrease from the $4.99 per share reported a year ago.

Portfolio Pulse from

February 10, 2025 | 4:45 pm

Alexander's, Inc. (NYSE: ALX) has declared a regular quarterly dividend of $4.50 per share, payable on February 28, 2025, to stockholders of record on February 18, 2025.

Portfolio Pulse from

February 05, 2025 | 6:15 pm

Alexander's, a REIT, has seen a decline in its stock price due to rising US 10-year Treasury yields. The company reported a decrease in FFO for Q3 2024 compared to the previous year. Despite a strong cash position, upcoming 2025 debt maturities present a challenge.

Portfolio Pulse from

January 26, 2025 | 3:30 am

ALX Oncology Holdings, Inc. announced the grant of an inducement stock option to its new CFO, Harish Shantharam, for 600,000 shares as part of his employment agreement, in accordance with Nasdaq rules.

Portfolio Pulse from

January 22, 2025 | 9:15 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.